Analysts Offer Insights on Consumer Cyclical Companies: DR Horton (DHI), Continental Aktiengesellschaft (OtherCTTAF) and Aptiv (APTV)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on DR Horton (DHI – Research Report), Continental Aktiengesellschaft (CTTAF – Research Report) and Aptiv (APTV – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DR Horton (DHI)
Evercore ISI analyst Stephen Kim maintained a Hold rating on DR Horton today and set a price target of $169.00. The company’s shares closed last Tuesday at $153.19.
According to TipRanks.com, Kim is a 5-star analyst with an average return of
DR Horton has an analyst consensus of Hold, with a price target consensus of $160.27, representing a 6.8% upside. In a report issued on January 6, Wells Fargo also downgraded the stock to Hold with a $155.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Continental Aktiengesellschaft (CTTAF)
In a report released today, Michael Aspinall from Jefferies maintained a Buy rating on Continental Aktiengesellschaft, with a price target of EUR75.00. The company’s shares closed last Tuesday at $77.07, close to its 52-week high of $79.26.
Aspinall has an average return of
According to TipRanks.com, Aspinall is ranked #1857 out of 12040 analysts.
Currently, the analyst consensus on Continental Aktiengesellschaft is a Moderate Buy with an average price target of $83.03, representing a 6.2% upside. In a report issued on January 13, UBS also maintained a Buy rating on the stock with a EUR80.00 price target.
Aptiv (APTV)
Oppenheimer analyst Colin Rusch maintained a Buy rating on Aptiv today and set a price target of $102.00. The company’s shares closed last Tuesday at $77.17.
According to TipRanks.com, Rusch is a top 100 analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aptiv with a $101.64 average price target, which is a 31.5% upside from current levels. In a report issued on January 12, Wells Fargo also maintained a Buy rating on the stock with a $99.00 price target.
